OQROGet OQRO Pro
Insider trade

Cadrenal Therapeutics (CVKD)CFO sold ~$69K

Matthew K Szot, CFO at Cadrenal Therapeutics, sold ~$69K of Cadrenal Therapeutics shares.

~$69K
Approx. value · 9,933 sh @ $6.97
Traded
Dec 29, 2025
Filed
Dec 31, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 10, 2025Company filing · Form 8-K · ResultsReported its results
  2. Nov 24, 2025Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On November 24, 2025, the Board of Directors (the “Board”) of Cadrenal Therapeutics, Inc. (the “Company”) appointed Lee Scott Golden, M.D. (“Dr. Golden”), to serve as a Class II director of the Company to hold office until the 2027 annual meeting of stockholders, at which time his term of office shall expire and a Class II director shall be elected for a full term of three years, or until his re-election or earlier…”
  3. Dec 10, 2025Company filing · Form 8-K · Material agreement, Reg FDSigned an important agreement, and shared information with investors (and 1 more item)
  4. Dec 15, 2025Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them
  5. Dec 29, 2025 · this disclosureInsiderCFO sold ~$69K of CVKD shares in the open market

What came next

  1. Mar 31, 2026Company filing · Form 8-K · ResultsReported its results
  2. Mar 31, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Cadrenal Therapeutics

OQRO holds no insider, Congress, fund or contract record for Cadrenal Therapeutics dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its CVKD page.

Other recent filings by Matthew K Szot, Chief Financial Officer

The full history of Matthew K Szot, Chief Financial Officer is on the profile page.

How this filing works

Other disclosures at Cadrenal Therapeutics

Everything OQRO holds on this company is on its CVKD page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data